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ABSTRACT The baculovirus Autographa californica multiple nucleopolyhedrovirus is
an insect virus with a circular double-stranded DNA genome, which, among other
multiple biotechnological applications, is used as an expression vector for gene de-
livery in mammalian cells. Nevertheless, the nonspecific immune response triggered
by viral vectors often suppresses transgene expression. To understand the mecha-
nisms involved in that response, in the present study, we studied the cyclic GMP-
AMP synthase-stimulator of interferon genes (cGAS-STING) pathway by using two
approaches: the genetic edition through CRISPR/Cas9 technology of genes encoding
STING or cGAS in NIH/3T3 murine fibroblasts and the infection of HEK293 and
HEK293 T human epithelial cells, deficient in cGAS and in cGAS and STING expres-
sion, respectively. Overall, our results suggest the existence of two different path-
ways involved in the establishment of the antiviral response, both dependent on
STING expression. Particularly, the cGAS-STING pathway resulted in the more rele-
vant production of beta interferon (IFN-) and IFN-1 in response to baculovirus in-
fection. In human epithelial cells, IFN-1 production was also induced in a cGAS-
independent and DNA-protein kinase (DNA-PK)-dependent manner. Finally, we
demonstrated that these cellular responses toward baculovirus infection affect the
efficiency of transduction of baculovirus vectors.
IMPORTANCE Baculoviruses are nonpathogenic viruses that infect mammals, which,
among other applications, are used as vehicles for gene delivery. Here, we demon-
strated that the cytosolic DNA sensor cGAS recognizes baculoviral DNA and that the
cGAS-STING axis is primarily responsible for the attenuation of transduction in hu-
man and mouse cell lines through type I and type III IFNs. Furthermore, we identi-
fied DNA-dependent protein kinase (DNA-PK) as a cGAS-independent and alternative
DNA cytosolic sensor that contributes less to the antiviral state in baculovirus infec-
tion in human epithelial cells than cGAS. Knowledge of the pathways involved in the
response of mammalian cells to baculovirus infection will improve the use of this
vector as a tool for gene therapy.
KEYWORDS STING, baculovirus, cGAS, gene delivery, interferons
The baculovirus (BV) Autographa californica multiple nucleopolyhedrovirus (Ac-MNPV), which infects arthropods, mainly from the order Lepidoptera, has a circular
double-stranded DNA (dsDNA) genome of 150 kb which encodes more than 150 viral
open reading frames (ORFs) (1). One of the main characteristics of this virus is that it
comprises two phenotypes throughout its viral cycle: the occlusion-derived virus and
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the budded virus, responsible for the primary infection and the viral dissemination,
respectively (2).
Since the 1980s, researchers have described the interactions between BVs and
mammalian cells (3). BVs are able to enter mammalian cells but cannot produce viral
progeny (4–8). BVs can transduce different cell types, such as epithelial, hepatic,
immune, and fibroblast cells, under mammalian promoters (3, 9, 10). This allows the use
of BVs as expression vectors in different research fields, including gene therapy, cellular
reprogramming, and genomic edition (3). Importantly, BV transduction efficiency is
regulated by the ability of virions to escape from the endosome and by intracellular
trafficking to the nucleus (11).
Several studies have reported that the nonspecific immune response triggered by
viral vectors, particularly BVs, might suppress transgene expression (12–14). BVs induce
high levels of type I interferon (IFN-I) in vivo and in vitro (15–19). The antiviral response
generated by BVs in vivo is strong enough to nonspecifically protect animals from lethal
doses of different viruses, such as foot-and-mouth disease virus, encephalomyocarditis
virus, influenza virus, and infectious bronchitis virus (15, 18, 20, 21). In fact, another
potential application field of BVs is their use as immunomodulators and adjuvants for
vaccines (22–24).
During a viral infection, the first line of defense is the innate immune response
produced by several cell types, such as dendritic cells, macrophages, and nonimmune
cells (i.e., fibroblast, endothelial, and epithelial cells) (25). The response of these cells
depends on pattern recognition receptors (PRRs), which detect and interact with
specific pathogen sequences called pathogen-associated molecular patterns (26). PRRs
include several proteins, such as Toll-like receptors (TLRs), which are expressed on the
cell surface and in endosomal compartments, and cytosolic PRRs, which sense patho-
gen nucleic acids in the cytoplasm (26). The DNA sensor family includes DNA-
dependent activator of IRFs (DAI), IFI16, DDX41, DNA-dependent protein kinase (DNA-
PK), RNA polymerase III (RNA Pol III), and cyclic GMP-AMP synthase (cGAS), among
others (26). Among them, the most relevant is cGAS, which promotes the synthesis of
2=3=-cGAMP, a strong activator of the stimulator of interferon genes (STING), involved
in the detection of different DNA pathogens producing IFN-I through the STING-TBK1-
IRF3 axis (27–31). STING is a key adaptor protein for most DNA- and RNA-sensing
pathways (32, 33). On the other hand, the cytosolic DNA sensor RNA Pol III transcribes
poly(dA-dT) DNAs in 5=-ppp RNA to induce IFNs through the retinoic acid-inducible
gene I (RIG-I) pathway (34, 35). This pathway is involved in the detection of several
organisms, including Legionella pneumophila and Epstein-Barr virus (34, 35). The
DNA-PK complex, which comprises Ku70, Ku80, and the catalytic subunit of DNA-PK
(DNA-PKcs), mediates the antiviral response triggered by cytosolic DNA dependent and
independent of STING. Particularly, Ku70 may participate in the induction of type III IFN
production in response to exogenous DNA (36).
The mechanisms involved in the innate immune response triggered by BVs are
unclear. In 2005, Abe et al. described a mechanism mediated by TLR9 in response to the
CpG motifs of the BV genome, which results in the production of proinflammatory
cytokines, IFN-I, and IFN-inducible chemokines (17). A TLR9-independent mechanism,
however, also exists, suggesting the importance of cytoplasmic DNA-sensing receptors
(37). Ono et al., in 2014, showed that STING signaling is involved in the sensing of BVs
in mouse embryonic fibroblasts (MEFs), as STING-deficient cells show more efficient
transduction and lower production of IFN- and proinflammatory cytokines than
wild-type STING-expressing cells (12). To date, no study has reported the involvement
of a cytosolic DNA detector in the cellular response to BV infection.
The aim of the present study was to evaluate the role of the cGAS-STING pathway
in BV-mediated IFN production in nonimmune mammalian cells by using two ap-
proaches: the genetic edition through clustered regularly interspaced short palindromic
repeat (CRISPR)/Cas9 technology of genes encoding STING or cGAS in NIH/3T3 murine
fibroblasts and the infection of HEK293 and HEK293 T human epithelial cells, deficient
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in cGAS or in cGAS and STING expression, respectively. We also evaluated the effect of
the antiviral state and of the sensors involved in the efficiency of BV transduction.
RESULTS
Baculovirus DNA is available in the cytosol of infected mammalian cells. To
determine whether BV DNA localizes in the cytosol during infection, available to
interact with nucleic acid cytosolic sensors, we produced an mCherry-reporter recom-
binant BV (Fig. 1A). The BV AcT7IRESmCherry carries mCherry cDNA downstream of the
T7 promoter sequence and an internal ribosomal entry site (IRES) element. This BV was
used to infect BSR-T7/5 cells, a BHK-21-derived cell line that stably expresses T7 RNA
polymerase in the cytoplasm (38), and BHK-21 cells were used as a control. The
expression of mCherry was detectable 24 h postinfection (hpi) in BSR-T7/5 cells but not
in BHK-21 cells (Fig. 1B), showing that expression of the cytoplasmic T7 RNA polymerase
was necessary for expression. To determine whether mCherry transcripts were pro-
duced from the T7 promoter and not from any BV promoter upstream of it, a 5= rapid
amplification of cDNA ends (5= RACE) of this transcript was performed in BSR-T7/5-
infected cells. The results (Fig. 1C) show that transcripts started immediately after the
T7 promoter sequence. This indicates that the viral DNA was available for cytosolic
transcription and can thus be recognized by DNA cytosolic sensors.
Baculoviruses induce an antiviral response mediated by STING and the pro-
duction of IFN-I through the cGAS-STING pathway in murine fibroblasts. After
FIG 1 Cytoplasmic transduction in BSR-T7/5 cells by AcT7IRESmCherry. (A) Schematic representation of the recombinant bacmid BacT7IRESmCherry, showing
the insertion site of the reporter gene, its orientation, and the surrender genes. mCherry was under the control of the T7 promoter and downstream of the IRES
of foot-and-mouth disease virus. (B) BSR-T7/5 and BHK-21 cells were infected with AcT7IRESmCherry at an MOI of 100 for 4 h and then incubated for 20 h.
mCherry expression was analyzed with a Zeiss microscope. The scale bar represents 20 m. (C) Transcriptional characterization of the mCherry gene in BSR-T7/5
cells infected with AcT7IRESmCherry. The sequenced DNA from a 5´ RACE assay (pGemT 5´ RACE sequence) was compared with the theoretical sequence of
the constructed bacmid.
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demonstrating that BV DNA was in the cytosol, we assessed the role of cytosolic DNA
sensors in the antiviral response. First, we investigated the cGAS-STING pathway in
murine fibroblasts after BV infection. For this purpose, our approach was the edition of
genes encoding STING or cGAS through CRISPR/Cas9 technology in NIH/3T3 murine
fibroblasts. By means of tracking of indels by decomposition (TIDE) analysis, we
corroborated a knockout efficiency of 97.9% for the genetic edition of STING in NIH/3T3
sting/ cells (Fig. 2A). The targeted gene had deletions of two or four nucleotides,
thus resulting in frameshift mutations. Unfortunately, a high GC content and repeats in
the sequence flanking the targeted cGAS impeded confirmation of the knockout
efficiency by TIDE analysis for this gene. Still, as demonstrated by other authors (39),
reverse transcriptase quantitative PCR (RT-qPCR) data (Fig. 2B) revealed that the ex-
pression of cGAS or STING in the cell lines generated was efficiently decreased.
We next evaluated the antiviral activity triggered by BV infection at different
multiplicities of infection (MOIs) in NIH/3T3 cells (Fig. 2C). The BV-mediated protection
against a vesicular stomatitis virus (VSV) infection varied between 89% and 71% when
BV MOIs of 100, 10, and 1 were used. In NIH/3T3 cgas/ cells, the antiviral response
detected after BV infection was reduced (24%, 19%, and 13% of cell protection when
using BV MOIs of 100, 10, and 1, respectively) and completely abrogated by STING
knockout in comparison to that of control cells (Fig. 2C). Trans-complementation of the
edited cells with expression plasmids coding for murine cGAS or STING restored the
ability to trigger an antiviral activity after BV infection, which was significantly higher
than that observed with transfection of the plasmid alone. These data suggest the
involvement of both molecules and the essentiality of STING, but not of cGAS, for the
establishment of an antiviral state by BV infection.
We next assessed the role of the cGAS-STING pathway in the production of IFN-
after BV infection by infecting NIH/3T3 murine fibroblasts with BV for 4 h and perform-
ing RT-qPCR analyses. BV-infected NIH/3T3 cells showed a 344.4  93.5-fold increase
(MOI, 100), a 236.0  39.1-fold increase (MOI, 10), and a 42.7  19.9-fold increase (MOI,
1) in IFN- mRNA levels in comparison to noninfected cells (Fig. 2D). In contrast, neither
NIH/3T3 sting/ nor NIH/3T3 cgas/ cells produced IFN- under these conditions
(Fig. 2D). The transcription of this cytokine was detected in cGAS or STING trans-
complemented edited cells and also in these transfected cells after infection.
Furthermore, when NIH/3T3 sting/ and NIH/3T3 cgas/ cells were coincubated
and then infected with BV, IFN- mRNA was significantly increased (Fig. 2D). This was
probably due to the 2=3=-cGAMP production of infected NIH/3T3 sting/ cells, which
activated STING in NIH/3T3 cgas/ cells. These data indicate that in murine fibroblasts,
the stimulation of IFN- production by BV infection depends on the complete cGAS-
STING pathway. As expected, edited fibroblasts produced IFN- mRNA in response to
VSV infection, showing that RNA-sensing pathways were not altered in these cells.
Poly(dA-dT) transfection of these cells induced the production of IFN- mRNA, which
suggests that the RNA Pol III sensor is functional and does not participate in BV-
mediated IFN- induction (Fig. 2D).
To study the RNA Pol III pathway in a deeper way and because of the high A-T
genomic content of BV, we used the chemical inhibitor of RNA Pol III, ML-60218, in
NIH/3T3 cells. This analysis revealed that pretreatment of the cells with the inhibitor did
not modify the antiviral activity or the levels of IFN- mRNA triggered by BV infection
at an MOI of 100 or 1 (Fig. 2E and F). As a control for the ML-60218 treatment, we used
the inhibition of the antiviral effect and the IFN- mRNA production induced by
transfection with poly(dA-dT). The results indicated that RNA Pol III is not involved in BV
DNA detection.
To evaluate whether the antiviral response detected in the absence of cGAS
expression was related to the induction of another type of IFN, we evaluated type III IFN
mRNA production. Although BV triggered a significant increase in IFN-2/3 mRNA in
the macrophage cell line RAW 264.7, murine fibroblasts showed no alterations in the
transcription levels of this cytokine after BV infection (data not shown).
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FIG 2 Antiviral activity and IFN-I mRNA induction by BV infection in murine fibroblasts. (A) TIDE analysis to quantify indel frequencies and
composition in NIH/3T3 sting/ cells. (B) STING and cGAS mRNA depletion assayed by RT-qPCR, with gapdh used as a housekeeping gene.
***, P  0.001 by permutation test for comparison of edited to control cells. (C and D) NIH/3T3, NIH/3T3 sting/, or NIH/3T3 cgas/ cells
were transfected with pcDNA3.1-Hygro()-mscGAS (cGAS) or pcDNAmSTING (STING). After 48 h, cells were transfected with poly(dA-dT)
(1 g/ml) or infected with BV (MOI of 100, 10, or 1) or with VSV at an MOI of 10. After 4 hpi, cells were infected with VSV at an MOI of
1 and the percentage of protection from VSV infection was calculated as described in Materials and Methods (C) or RNA was extracted
and RT-qPCR assays were performed (D). (E and F) NIH/3T3 cells were treated with ML-60218 (20 M) for 2 h and then transfected with
poly(dA-dT) (1 g/ml) or infected with BV at an MOI of 100 or 1. At 4 hpi, cells were infected with VSV at an MOI of 1 and the percentage
of protection was calculated as described in Materials and Methods (E) or RNA was extracted and RT-qPCR assays were performed (F). All
the data from three independent experiments in biological triplicates were averaged and are shown as means  SD. gapdh was used as
(Continued on next page)
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Baculoviruses induce the establishment of a STING-dependent antiviral re-
sponse, IFN-I and IFN-III production through the cGAS-STING pathway, and in-
duction of IFN-III through a DNA-PK sensor in human epithelial cells. We next
studied BV infection of HEK293 and HEK293 T human epithelial cells, which are deficient
in cGAS or in cGAS and STING expression, respectively (Fig. 3A). First, we evaluated the
antiviral activity induced by BV by measuring the VSV titer 16 hpi. In the absence of
cGAS, only human epithelial cells that express STING (HEK293) displayed antiviral
activity in response to BV infection at MOIs of 100, 10, and 1 (Fig. 3B and C). In HEK293
cells, trans-complementation showed no informative results due to the strong antiviral
activity triggered by transfection with a cGAS expression plasmid (data not shown). In
concordance with the results obtained in infected HEK293 cells, trans-complementation
of HEK293 T cells with a STING expression plasmid before BV infection induced a
decrease in VSV production (Fig. 3C). Cotransfection with both cGAS and STING
expression plasmids before BV infection resulted in higher antiviral activity (Fig. 3C).
In concordance with the results obtained in murine fibroblasts, neither HEK293 nor
HEK293 T cells produced IFN- mRNA after BV infection at any of the MOIs evaluated
(Fig. 3D). These findings highlight the essential role of cGAS in this response and
confirm that the RNA Pol III pathway, which is functional in these cells, is not involved
in BV detection. As observed for the antiviral activity, trans-complementation of HEK293
cells with the cGAS expression plasmid triggered high levels of IFN- mRNA, thus
preventing the measurement of the BV infection effect (data not shown). In HEK293 T
cells, BV infection stimulated IFN- mRNA production only after cotransfection with
cGAS and STING expression plasmids (Fig. 3D).
Next, we studied IFN-III production in infected HEK293 and HEK293 T cells. As shown
in Fig. 3E, IFN-1 mRNA was detectable only in the presence of STING, either in HEK293
cells or in transfected HEK293 T cells with the STING expression plasmid. The induction
of IFN-1 mRNA in HEK293 cells ranged from 17.3  2.8 to 2.7  0.4 for BV MOIs of 100,
10, and 1. Pretreatment with NU7026, a DNA-PKcs kinase inhibitor, significantly reduced
IFN-1 mRNA induction in HEK293 cells. Trans-complementation with cGAS in HEK293
cells or with cGAS and STING in HEK293 T cells potentiated the BV-mediated IFN-1
mRNA production, which reached 38.9  10.5- and 127.0  50.6-fold increased levels,
respectively, using a BV MOI of 100 (Fig. 3E).
These results indicate that the cGAS-STING pathway is relevant in the production of
IFN-1 in response to BV infection. In the same way as observed for antiviral activity,
where STING is essential, cGAS reinforces the type III IFN response after BV infection. In
human epithelial cells, although not in murine fibroblasts, the antiviral effect observed
in the presence of STING and the absence of cGAS may be explained by type III IFN
production after DNA-PK sensing.
The cGAS-STING pathway is involved in transduction efficiency in mammalian
cell lines. BVs can transduce several types of mammalian cells with variable efficiency
(3, 10). To analyze the performance of some nonimmune cells to express a transgene
driven by a BV vector, we compared different cell types: HEK293 T, HEK293, BHK-21,
MEFs, and NIH/3T3 cells. The cells were infected with the recombinant BV AcCAGeGFP,
which carries an egfp reporter gene under the control of the CAG promoter (a strong
synthetic mammalian promoter), to assess the expression of enhanced green fluores-
cent protein (eGFP) 24 hpi. The different cells evaluated showed high variability of
transduction efficiency (Fig. 4A). BHK-21 and HEK293 T cells displayed the most efficient
transduction, whereas NIH/3T3 cells showed relatively low efficiency. This difference
might arise from intrinsic cell physiologies influencing viral trafficking to the nucleus
but also from diverse cellular responsiveness to viral infection. In accordance with the
antiviral state induced by BV in HEK293 cells, this cell type showed lower transduction
FIG 2 Legend (Continued)
the housekeeping gene. The permutation test was used for comparisons of each treatment to untreated cells (indicated above each
column: *, P  0.05; **, P  0.01; ***, P  0.001). Statistical analyses among treatments were performed by a t test or one-way analysis of
variance (ANOVA) followed by Bonferroni’s test (*, P  0.05; ***, P  0.001).
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than HEK293 T cells. Thus, the expression of eGFP driven by a plasmid was studied in
BV-infected and noninfected HEK293 and HEK293 T cells. Only infected HEK293 cells
displayed significantly lower mean fluorescence intensity at 16 hours posttransfection
than noninfected cells (Fig. 4B). These results indicate that even in the absence of cGAS,
a condition that does not allow IFN- production, BV infection was able to induce an
antiviral state through STING, which modulated the efficiency of a transgene expression
independently of how it was vectorized.
Next, the participation of cGAS and STING in the efficiency of a transgene expression
driven by BV vectors was evaluated, or confirmed in the case of STING, by measuring
FIG 3 Antiviral activity and IFN-I and -III mRNA induction by BV infection in human epithelial cells. (A) Characterization of cGAS and STING expression in HEK293
and HEK293 T cells by Western blotting. (B and C) HEK293 (B) or HEK293 T (C) cells were transfected with pTRIP-CMV-Puro-2A-cGAS (cGAS) or pcDNAhSTING
(STING) and, after 48 h, infected with BV at an MOI of 100, 10, or 1. At 4 hpi, cells were infected with VSV at an MOI of 0.1. Sixteen hours later, VSV production
was determined in Vero cells. (D and E) As indicated in the figure, some HEK293 cells were transfected only with poly(dA-dT) (1 g/ml) or were pretreated with
NU7026 (30 M) for 16 h, and some HEK293 T cells were transfected with pTRIP-CMV-Puro-2A-cGAS (cGAS) or pcDNAhSTING (STING). After 48 h, cells were
infected with BV at an MOI of 100, 10, or 1. After 4 h, RNA was extracted and RT-qPCR assays were performed. All the data from three independent experiments
in biological triplicate were averaged and are shown as means  SD.  actin was used as the housekeeping gene. The permutation test was used for
comparisons of each treatment to untreated cells (indicated above each column: *, P  0.05; **, P  0.01; ***, P  0.001). Statistical analyses among treatments
were performed by a t test or one-way ANOVA followed by Bonferroni’s test (*, P  0.05).
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eGFP fluorescence in edited NIH/3T3 cells. The expression of eGFP from AcCAGeGFP
was dramatically increased in the edited cells (Fig. 4C), thus indicating that both STING
and cGAS affect BV transduction.
Next, the transcription of the reporter gene was measured by RT-qPCR in control
and edited NIH/3T3 cells at 24 hpi. The relative expression of eGFP mRNA was
significantly higher in the knockout cells than in the control cells (264%  8% for
NIH/3T3 sting/ cells and 273%  6% for NIH/3T3 cgas/ cells). In contrast, no
differences were detected between the two types of edited cells (Fig. 4D).
In addition, the transport of nucleocapsids to the nucleus in NIH/3T3 cgas/ cells
was studied by immunofluorescence confocal microscopy with an antibody directed to
the major capsid protein of BV, VP39. In coincidence with the results of RT-qPCR, the
immunofluorescence assay showed that at 6 hpi, the number of cells with viral particles
detected in the nucleus was significantly higher in NIH/3T3 cgas/ cells (Fig. 4E). This
finding suggests that the cGAS-STING pathway modulates viral trafficking and, conse-
quently, the efficiency of viral transcription. However, the magnitude of these differ-
FIG 4 Transduction efficiency in nonimmune mammalian cells by infection with BV. (A) Different cell lines were infected with BV AcCAGeGFP at an MOI of 100
for 4 h and then incubated for 20 h. eGFP expression was analyzed with a Zeiss microscope, and mean fluorescence was quantified using ZEN 2.3 software.
(B) HEK293 or HEK293 T cells were infected (BV) or not (BV) with wild-type BV for 4 h at an MOI of 100 and then transfected with pcDNAeGFP. Mean
fluorescence was quantified using ZEN 2.3 software. (C and D) NIH/3T3, NIH/3T3 sting/, or NIH/3T3 cgas/ cells were infected with AcCAGeGFP at an MOI
of 100 for 4 h and then incubated for 20 h. eGFP expression was analyzed with a Zeiss microscope and the number of eGFP-positive cells was quantified, and
100% corresponded to NIH/3T3 control cells (C). The relative expression of eGFP mRNA was evaluated by RT-qPCR, and 100% corresponded to NIH/3T3 control
cells. gapdh was used as the housekeeping gene (D). (E) NIH/3T3 or NIH/3T3 cgas/ cells were infected with BV at an MOI of 50, and at 6 hpi, viral particles
were evidenced inside cells by immunofluorescence confocal microscopy using anti-VP39 antibody. Nuclei were stained using TOPRO-3. The numbers of cells
with viral particles inside the nucleus were compared, and 100% corresponded to NIH/3T3 control cells. Statistical analyses were performed by a t test or
one-way ANOVA followed by Bonferroni’s test (*, P  0.05; ***, P  0.001). Scale bars, 20 m (A, B, and C) or 10 m (E).
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ences does not seem to fully explain the efficiency of BV transduction in edited cells.
Thus, we postulate an additional translational effect.
In summary (Fig. 5), our results showed that RNA Pol III is not relevant in the
detection of the BV genome and that STING is required for the establishment of an
antiviral state in nonimmune mammalian cells. At least two different signaling path-
ways have an impact on STING and contribute to the antiviral state induced by BV. The
detection of the viral genome by the cGAS sensor induces the strongest cellular
response, and furthermore, this DNA sensor is necessary for IFN- production. In
addition, the cGAS-independent STING activation produces an antiviral state in human
and murine cells. In human epithelial cell lines, the antiviral response correlates with the
DNA-PK-mediated production of IFN-1.
DISCUSSION
The baculovirus AcMNPV is able to transduce genes under the control of an
adequate promoter in mammalian cells, although it cannot replicate its genome in
these hosts. Besides this potential for gene delivery, BVs can also be used for vaccine
development and immunomodulation (22–24). This work aimed to evaluate the par-
ticipation of cytosolic DNA sensors in the antiviral response induced by BV infection and
its relevance in BV transduction in nonimmune mammalian cells.
FIG 5 Innate immune signaling pathways modulating BV transgene expression. BV infection activates at least two different STING-dependent signaling
pathways: the cGAS-dependent signaling pathway (black arrows), which activates the STING-TBK1-IRF3 axis, inducing type I IFN production and exacerbating
the production of type III IFN, and the DNA-PK-dependent pathway (blue arrows), which produces IFN-1 in human epithelial cells. All of these responses
suppress BV transgene expression (red) by affecting the transport of nucleocapsids to the nucleus and the transcription and translation of the transgene. RNA
Pol III is not a relevant cytosolic nucleic acid sensor in BV infection (orange arrows).
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The infection of mammalian immune cells by BVs induces a strong innate immune
response and can generate a nonspecific antiviral state, triggering the production of
IFN-, IFN-, and proinflammatory cytokines (17, 37). Furthermore, BV infection pro-
duces maturation of dendritic cells and stimulates natural killer cells, generating IFN-
(19, 40, 41). Because of the high frequency of CpG motifs in the BV genome, TLR9/
MyD88 has been the most studied pathway (17, 37). Nevertheless, in vivo studies have
shown partial reduction of IFN- and interleukin 12 (IL-12) in MyD88/ mice (17). In
addition, IFN- and IFN- production are completely or partially independent of TLR9
and MyD88, respectively (17, 37). Thus, researchers began to study other PRRs and,
therefore, identified the adaptor molecule STING as a central mediator of systemic IFN-I
levels (12). Yet, to date, the mechanisms involved in DNA sensor and STING activation
remain uncharacterized.
In this work, we showed the accessibility of BV genomes in the cytosol of mamma-
lian cells. Some evidence shows that most BV nucleocapsids are retained in mammalian
cell endosomes (11). However, nuclear importation or cytoplasmic traffic suffers a
blockage in these cells (11). Regarding the accessibility to gene transcription, we have
previously demonstrated the presence of viral genomes in the cytoplasm of BHK-21
cells; nevertheless, we were not able to rule out a disassembling of inner cellular
membranes or disruption of actin microfilaments by the vaccinia virus used as a tool
and subsequent detection of endosomal DNA (42). Fluorescent in situ hybridization
(FISH) assays in PK1 cells (6) and DNA detection in the cytoplasm of rat chondrocytes
(16) by qPCR might allow the detection of endosomal content. In the present work, the
BSR-T7/5 system allowed us to evaluate, for the first time, the presence of BV DNA
without disrupting cellular structures. In this way, we showed that BV particles, despite
being viral vectors with a proven ability to express transgenes in mammalian cell nuclei,
are frequently retained in the cytoplasm and that they disassemble and remain
available to interact with cellular sensors.
Some nonimmune cells, like fibroblasts, are central in IFN-I production in response
to viral infections, in particular by producing high levels of IFN-. BV infection in MEFs
stimulates IFN-I synthesis (37). Ono et al., in 2014, reported that STING-, TBK1-, or
IRF3-deficient MEFs showed affected IFN- induction by BV (12). In addition, they
reported the translocation of STING toward the perinuclear zone after BV infection,
while Takama et al., in 2017, showed that silencing of RAB2 and GARIL5, two proteins
that modulate IRF3 phosphorylation through the STING-TBK1 axis, decreases IFN-
production in BV-infected MEFs (12, 43). In infections with DNA viruses, cGAS is the
most relevant detector producing the activation of the STING-TBK1-IRF3 axis; probably
for this reason, it has been considered necessary in STING activation by BV infection
(43, 44).
In our work, we studied the cGAS-STING pathway by using edited murine fibroblasts
and human epithelial cells with deficiencies in cGAS and differential expression of
STING. The selection of edition of NIH/3T3 cells over the small interfering RNA
(siRNA) strategy was because some researchers detected IFN-stimulated genes 12 h
poststimulus despite their being silenced (43). In this analysis, both genes showed
an overexpression in BV-infected NIH/3T3 cells (data not shown). In addition, siRNA
transfection promotes a nonspecific induction of inflammatory cytokines and type
I and III IFNs (45).
Herein, we demonstrated that STING is essential for the establishment of an antiviral
state by BVs in murine fibroblasts and human epithelial cells. We also proved the
involvement of cGAS in BV detection and the existence of an alternative sensing
mechanism. In addition, we showed that the cGAS-independent antiviral activity was
unrelated to IFN- synthesis, since the production of this cytokine kept a strict
correlation with the presence of the aforementioned DNA sensor. This research thus
shows the importance of the cGAS sensor regarding the strength of the response. In
2018, Costa Franco et al. showed the importance of cGAS in IFN-I production in
response to infection by Brucella abortus and demonstrated that STING, but not cGAS,
is critical for controlling the infection in macrophages and in vivo (46). As with that
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previously described for Listeria monocytogenes (47), c-di-GMP produced by Brucella
activates STING (46). For DNA viruses, however, no similar cGAS-independent mecha-
nism has been described.
The essentiality of both cGAS and STING for BV-mediated triggering of IFN-
production in murine fibroblasts was confirmed by infection of a mix of edited cells. The
second messenger 2=3=-cGAMP, synthesized by the activation of cGAS, is spread from
one cell to another by gap junctions (48) and secreted to the extracellular medium,
from which it can be taken by nearby cells (49). The reestablishment of IFN-I production
after stimulation with BV shows that edited cells were not impeded for transcription of
this cytokine and states the critical role of 2=3=-cGAMP in BV-mediated induction of the
IFN-I response. In HEK293 T cells, cGAS participation in BV-induced IFN- production
could be demonstrated by trans-complementation with cGAS and STING. Study of the
BV effect by complementation assays in these cells could be performed since STING
levels achieved by transfection may not be as high as the endogenous levels in HEK293
cells.
The source of STING activation determines the signaling pathway to be triggered
(50). STING is subject to multiple posttranslational modifications (50). Although the
precise molecular function of these modifications remains unclear, they play together
to obtain the appropriate response in each case (50). Our results showed concordance
between antiviral activity and IFN-III production in BV-infected human epithelial cells.
Although the mechanisms involved in the differential induction of IFN-I or -III are
unknown, it is accepted that it depends on the use of different signaling molecules or
transcription factors. IFN-1 and IFN-3 promoters contain binding sites for IRF1, IRF3,
IRF7, and NF-B, but unlike IFN-I synthesis, which requires the joint participation of
several transcription factors, IFN- transcription may depend mainly on IRF1, IRF7, and
NF-B to a lesser extent (51, 52). Our results using BV as a dsDNA stimulus are in
agreement with those described by Zhang et al. in 2011 (36), who found that HEK293
cells, but not HEK293 T cells, produce IFN- in response to dsDNA (36). Sui et al., in
2017, further demonstrated the participation of the Ku70 sensor in DNA detection, the
interaction of Ku70 with STING, and the STING-dependent increase of IRF1 and IRF7 but
not of IRF3 (53). These mechanisms may also be operating in BV genome sensing.
Although DNA-PKcs was not necessarily required for the interaction between Ku70
and STING (54), our findings show that the kinase activity of DNA-PKcs is essential
for BV-mediated IFN-1 production. Trans-complementation with cGAS in HEK293
cells and with cGAS-STING in HEK293 T cells increased the production of IFN-1 by
BV, probably by the restoration of the IRF3 pathway. Ding et al. demonstrated that
2=3=-cGAMP induces the transcription not only of IFN-I but also of IFN-III (55). On the
other hand, the antiviral activity stimulated in NIH/3T3 cgas/ cells was not the
result of inefficient edition of the gene, as evidenced by the total lack of IFN-
induction. However, it coincides with the data obtained in HEK293 cells. In NIH/3T3
cgas/ cells, unlike in human epithelial cells, BV did not promote IFN-III transcrip-
tion. In contrast, in RAW 264.7 cells, BV promoted IFN-2/3 synthesis, showing that
murine cells can produce this cytokine after infection with BV. In addition, the
antiviral activity produced by BV in NIH/3T3 cgas/ cells was not modified when
a DNA-PK inhibitor was used (data not shown). These findings suggest an alterna-
tive route of a different sensor that induces an antiviral response mediated by other
cytokines.
In BV-infected NIH/3T3 cells, the chemical inhibition of RNA Pol III did not affect the
antiviral response or induction of IFN- mRNA transcription. Accordingly, BV did not
stimulate IFN- mRNA production in HEK293 or HEK293 T cells, where the RNA Pol III
pathway is active, as shown by the results obtained by poly(dA-dT) transfection. DNA
virus activation of mitochondrial antiviral-signaling protein (MAVS), a molecule involved
in RNA detection through RIG-I stimulation, has been described through RNA Pol III
participation (34, 35). Our results cannot explain why BV-infected MEFs produce lower
levels of IFN- if they are prepared from MAVS-deficient mice (12). We cannot rule out
the sensing of dsRNA structures from some viral transcript, which activates RIG-I/MAVS-
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mediated antiviral signaling in fibroblasts. In HEK293 and HEK293 T cells, this pathway
is functional and, as shown in the present study, is not activated by BV infection. The
differences in responsiveness to BV infection between cell types can be explained by
differential BV transcriptomes in mammalian cells postinfection, as previously reported
(56–58).
In accordance with previous results (9), in the present study, nonimmune mamma-
lian cells displayed a very variable efficiency to express transgenes contained in the BV
genome. As mentioned before, the endosomal escape has been pointed out as the
limiting step for BV transduction (11). However, some evidence suggests that IFN-I
production interferes with viral transit into the cell (59), increases intracellular pH (60),
downregulates actin mRNA expression (61), and prevents its reorganization (62). More-
over, IFN-I production causes changes in gene transcriptional restriction due to inter-
ference with the binding of transcriptional factors and with RNA polymerase II elon-
gation (63, 64). All these cell responses induced by IFNs directly affect transgene
expression driven by a viral vector. A high-throughput short hairpin RNA (shRNA) library
screening identified 43 host factor genes that restrict BV transduction in A549, a human
lung carcinoma-derived cell line (13). In addition, Lee et al. described the relation
between BV-induced IFN- and the transgene expression driven by BV in supertrans-
duction experiments (16). In our work, the efficiency of transgene expression in
nonimmune cell lines correlated with the antiviral state induced by the BV carrying the
reporter gene. BHK-21, a cell line with proven inability to produce IFNs, was transduced
with high efficiency, whereas NIH/3T3 cells displayed a strong antiviral activity and were
poorly transduced. BV infection resulted in the reduction of VSV production in HEK293
cells but not in HEK293 T cells (which had a more efficient transduction). Thus, as
previously shown in MEFs (12), STING expression in human epithelial cells affected BV
transduction. Moreover, the antiviral state induced by BV in this type of cells worsened
the reporter expression driven by a different vector. The antiviral activity that modu-
lates transduction efficiency in these epithelial cells is independent of IFN- and can be
explained by the production of IFN-1. In murine fibroblasts, we not only confirmed the
role of STING in the modulation of transduction efficiency but also demonstrated that
cGAS is involved in this process. Indeed, we showed that the cGAS-STING pathway
decreases the number of viral particles that reach the cell nucleus and the number of
reporter gene transcripts, but mainly reporter fluorescence, thus suggesting a transla-
tional effect. These results coincide with a previous report in which a preceding
infection with BV affected translation, but not transcription, of a transgene driven by
another BV in chondrocytes (16).
In conclusion, the detection of BV genomes by the cGAS-STING nucleic acid sensing
pathway plays a decisive role in establishing an antiviral state given by IFN-I and -III,
which affects the efficiency of BV as a gene transporter.
MATERIALS AND METHODS
Cell cultures. The Sf-9 insect cell line, a clonal isolate from the parental Spodoptera frugiperda cell line
IPLB-Sf21-AE, was purchased from Invitrogen and maintained at 27°C in TNMFH insect medium (Sigma)
supplemented with 10% fetal bovine serum (FBS) (Internegocios). NIH/3T3 (ATCC), Vero (ATCC), HEK293
(ATCC), HEK293 T (ATCC), RAW 264.7 (ATCC), THP-1 (ATCC), and BSR-T7/5 (38) cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS in a 5% CO2 atmosphere at
37°C. BSR-T7/5 cells were cultured with Geneticin (Gibco) (1 mg/ml) at every second passage. MEFs were
obtained as described by Jozefczuk et al. (65).
Plasmids, bacmid, and viruses. Wild-type AcMNPV was obtained from Pharmingen (BD Biosci-
ences). The AcCAGeGFP virus was constructed previously (42). AcT7IRESmCherry was generated using
the Bac-to-Bac system.
For the preparation of BV stocks, Sf-9 cells grown in 175-cm2 flasks were infected at an MOI of 0.05,
and at 4 dpi, the supernatants were collected and clarified. Virus titers were determined by an endpoint
dilution assay by using a GFP infection-induced cell line as previously described (66).
VSV Indiana strain stocks were prepared by infecting Vero cells grown in 175-cm2 flasks at an MOI of
0.1 and collecting the supernatants at 2 dpi. Virus titers were determined by an endpoint dilution assay
in Vero cells (67).
BacT7IRESmCherry was constructed by first amplifying the T7IRES sequence using primers T7IRESfor,
5=-GCGCATGCTTAATACGACTCACTATAG-3=, and T7IRESrev, 5=-GCCCATGGAGGGTCATTAATTGTAA-3=, and
the plasmid pIC-LUC (provided by Encarnación Martínez-Salas, Centro de Biología Molecular Severo
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Ochoa [CBMSO], Spain), as a template. The linear PCR fragment was gel purified and cloned into pGEM-T
Easy vector systems (Promega) to obtain pGemT-T7IRES. This plasmid was digested with the enzymes
PvuII and SpHI and cloned into the pFBDmCherry plasmid (42) digested with the same enzymes, to
obtain pFBD-T7IRESmCherry.
The plasmid pcDNAhSTING was constructed by amplifying the hSTING sequence with primers
hSTINGfor, 5=-GCGAATTCATGCCTCATTCCAGCC-3=, and hSTINGrev, 5=-CGTCTAGATTAAGAGAAATCCG
TGC-3=, and using DNA extracted from HeLa cells as a template. The PCR fragment was gel purified and
cloned into pCR 2.1-TOPO TA (Invitrogen) to obtain pTOPO-hSTING. This plasmid was digested with EcoRI
and XbaI (underlined) and cloned into the pcDNAeGFP plasmid digested with the same enzymes to
obtain pcDNA-hSTING. pcDNAmSTING was similarly constructed using the DNA of NIH/3T3 cells as a
template and the following primers: mSTINGfor, 5=-GCGAATTCATGCCATACTCCAACC-3=, and mSTINGrev,
5=-CGTCTAGATTTAGATGAGGTCAGTG-3=. The insertion was confirmed by sequencing (Unidad de
Genómica [IABIMO, Hurlingham, Argentina]). The expression plasmids of murine cGAS [pcDNA3.1-Hygro
()-mscGAS] and human cGAS (pTRIP-CMV-Puro-2A-cGAS) were gifts from the Nicolas Manel Lab
(Addgene plasmid number 102607 [http://n2t.net/addgene:102607] and Addgene plasmid number
102612 [http://n2t.net/addgene:102612]) (68).
Transduction assays. Cells were seeded into 96-multiwell culture plates at a density of 1  105
cells/well (NIH/3T3, NIH/3T3 sting/, and NIH/3T3 cgas/ cells) or 1.6  104 cells/well (HEK293, HEK293
T, BHK-21, MEF, and BSR-T7/5 cells) and cultured overnight. They were then incubated with AcCAGeGFP
or AcT7IRESmCherry at an MOI of 100 (centrifuged at 13,000  g and resuspended in TNMFH-phosphate-
buffered saline (PBS) [1:4]) at 27°C for 4 h. Subsequently, the supernatants were removed and the cells
were washed three times with PBS before the addition of fresh culture medium. After 20 h at 37°C, eGFP
or mCherry expression was analyzed using a fluorescence microscope (Zeiss).
5´ RACE. BSR-T7/5 cells were incubated with AcT7IRESmCherry at an MOI of 100 at 27°C for 4 h and
washed three times with PBS before the addition of fresh culture medium. At 16 hpi, total RNA was
isolated by using TRIzol reagent (Invitrogen), and cDNA 5= ends were rapidly amplified using the 5= RACE
system version 2.0 (Invitrogen), in accordance with the manufacturer’s instructions. For cDNA synthesis,
the primer was mCherryRT 5=-AGGCCTTCCTTCTCCTTCAC-3=. For the PCR, the primers were Abridged
Anchor primer, Abridged universal amplification primer (Invitrogen), and reverse primer IRESrace 5=-CG
TGCTGGGGTTGCACAC-3=. Sequences were obtained after cloning in the pGEM-T Easy vector.
Transfections. The purified bacmid was transfected using 1 g of DNA per 1  106 Sf-9 cells by using
Cellfectin II reagent (Invitrogen), in accordance with the manufacturer’s suggestions.
Mammalian cells were transfected using Lipofectamine 3000 transfection reagent (ThermoFisher
Scientific), in accordance with the manufacturer’s suggestions.
Generation of STING- and cGAS-deficient cells with CRISPR-Cas9 technology. A single guide RNA
targeting STING exon 1 (5=-GAAGATGAGGGCTACATATT-3=) or cGAS exon 1 (5=-GGGCTGGGGCTCCCGTA
CGG-3=) (69) was cloned into the pSPgRNA plasmid to generate pSPgSTING or pSPgcGAS. pSPgRNA was
a gift from the Charles Gersbach lab (Addgene plasmid number 47108; http://n2t.net/addgene:47108)
(70). Then, 5  107 NIH/3T3 cells were centrifuged and resuspended in 200 l of HBS (HEPES, 20 mM;
NaCl, 150 mM; Ficoll 400, 0.5%; pH 7.2) and then electroporated (180 V, 2,000 F, ∞R; 4-mm cuvettes;
Bio-Rad) with 10 g of pSPgSTING, pSPgcGAS, or pSPgRNA (control cells) and 7 g of pST1374-NLS-flag-
linker-Cas9. pST1374-NLS-flag-linker-Cas9 was a gift from the Xingxu Huang lab (Addgene plasmid
number 44758; http://n2t.net/addgene:44758) (71). After 24 h, cells were selected with Blasticidin
(2.5 g/ml; Gibco) for 24 h. Single-cell clones were obtained from cells plated at 0.5 cells/well into 96-well
plates. For NIH/3T3 sting/ cells, the STING sequence was amplified using primers STINGKOfor (5=-CA
ACAGTAGTCCAAGTTCGTG-3=) and STINGKOrev (5=-CTCAGACCTGGTTTATGGAGGC-3=) and genomic DNA
from edited and control cells as a template. The purified amplicon was sequenced. Indel frequencies
were quantified using TIDE software (72).
Antiviral activity assays. (i) NIH/3T3 cells. A total of 1  105 NIH/3T3, NIH/3T3 sting/, or NIH/3T3
cgas/ cells were seeded onto 96-multiwell culture plates and either transfected or not with 250 ng of
pcDNA3.1-Hygro()-mscGAS or pcDNAmSTING. After 48 h, the cells were infected with BV at an MOI of
1, 10, or 100 or stimulated with poly(dA-dT) (1 g/ml; InvivoGen). For the RNA Pol III inhibition assay, cells
were pretreated with ML-60218 (Cayman Chemical) at 20 M for 2 h. After 4 hpi, BV was removed and
the cells were washed twice with PBS. The cells were infected with VSV at an MOI of 1 and, after 16 hpi,
stained with crystal violet. The absorbance at 595 nm was measured using a Multiskan Spectrum
spectrophotometer (Thermo Scientific). The antiviral activity was calculated as the percentage of
protection, where 100% corresponded to cells without infection and 0% corresponded to cells infected
with VSV.
(ii) HEK293 and HEK293 T cells. A total of 3.2  104 cells were seeded into 48-multiwell culture
plates and either transfected or not with 250 ng of pTRIP-CMV-Puro-2A-cGAS or pcDNAhSTING. After 48
h, the cells were infected with BV at an MOI of 1, 10, or 100. After 4 hpi, BV was removed and the cells
were washed twice with PBS. The cells were then infected with VSV at an MOI of 0.01, and after 16 h, the
supernatants were removed and virus titers were determined by an endpoint dilution assay in Vero cells.
RT-qPCRs. A total of 2  105 (NIH/3T3, NIH/3T3 sting/, or NIH/3T3 cgas/ cells) or 3.2  104
(HEK293 or HEK293 T cells) cells were seeded into 48-multiwell culture plates and either transfected or
not with 500 ng of pcDNA3.1-Hygro()-mscGAS, pTRIP-CMV-Puro-2A-cGAS, pcDNAmSTING, or pcDNA-
hSTING. After 48 h, the cells were infected with BV at an MOI of 1, 10, or 100 or with VSV at an MOI of
10 or stimulated with poly(dA-dT) (1 g/ml). For RNA Pol III and DNA-PK inhibition treatments, cells were
pretreated with ML-60218 or NU7026 (Abcam) at a concentration of 20 M for 2 h or 30 M for 16 h.
After 4 hpi, BV was removed and the cells were washed twice with PBS. Total RNA was isolated by using
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TRIzol reagent (Invitrogen). Residual DNA was removed by using a Turbo DNase-free kit (Life Technol-
ogies). Equal amounts of total RNA (1 g) were used to synthesize cDNA with Moloney murine leukemia
virus (M-MLV) reverse transcriptase (Promega) and random primers (Biodynamics). Gene expression was
analyzed by RT-qPCR. Briefly, FastStart universal SYBR green master (Rox) (Roche) was used and reactions
were made on an Applied Biosystem 7000 SDS using standard cycling conditions. All reactions were
performed in duplicate, and qPCR data were analyzed using the 2ΔΔCT method with efficiency correction
as described previously (73). Differences in cytokine expression between groups were assessed with
gapdh or  actin as control genes, and data from the control group were used for calibration. The primers
were as follows:  h-actin F, 5=-TGACGGGGTCACCCACACTG-3´;  h-actin R, 5=-AAGCTGTAGCCGCGCTCG
GT-3=; murine GAPDH F, 5=-GCCTTCCGTGTTCCTACCC-3=; murine GAPDH R, 5=-TGCCTGCTTCACCACCTTC
T-3=; hIFN  F, 5=-CGCCGCATTGACCATCTA-3=; hIFN  R, 5=-GACATTAGCCAGGAGGTTCTCA-3=; hIFN 1 F,
5=-CGCCTTGGAAGAGTCACTCA-3=; hIFN 1 R, 5=-GAAGCCTCAGGTCCCAATTC-3=; mIFN 2/3 F, 5=-AGCTG
CAGGTCCAAGAGCG-3=; mIFN 2/3 F, 5=-GGTGGTCAGGGCTGAGTCATT-3=; mIFN  F, 5=-ACACCAGCCTGG
CTTCCATC-3=; mIFN  R, 5=-TTGGAGCTGGAGCTGCTTATAGTTG-3=; qGFP F, 5=-ATGGTGAGCAAGGGCGGA
G-3=; qGFP R, 5´-CACGCTGAACTTGTGGCC-3=; mSTING F, 5=-CTTCAGAGCTTGACTCCAGC-3=; mSTING R,
5=-TGTACAGTCTTCGGCTCCCT-3=; mcGAS F, 5=-AAGGCAGCTGGCCTATTAGT-3=; mcGAS R, 5=-CGCCAGGTC
TCTCCTTGAAA-3=.
Western blot analyses. A total of 1  106 HEK293, HEK293 T, and THP-1 cells were boiled for 5 min
in disruption buffer (120 mM Tris-HCl, pH 6.8, 4% SDS, 0.02% bromophenol blue, 1.4 M
-mercaptoethanol, 20% glycerol), and proteins were resolved in 12% acrylamide-bisacrylamide (30:0.8)
SDS-PAGE minigels (Bio-Rad). The proteins were blotted onto nitrocellulose membranes, and the blots
were probed with rabbit polyclonal anti-cGAS (1:300) or anti-STING (1:300) antibodies (Sigma catalog
numbers PA5-76367 and PA5-70420, respectively), followed by anti-rabbit horseradish peroxidase (HRP)-
conjugated antibody (1:1,000; Sigma catalog number A6154). The blots were revealed by using Super-
Signal West Femto maximum sensitivity substrate (Thermo Scientific).
Image analysis. The fluorescence intensity in HEK293 and HEK293 T cells was analyzed using ZEN
2.3 software (Zeiss). Six randomly selected fields of each treatment were analyzed, and the mean intensity
was calculated according to predetermined software conditions.
Confocal images were acquired in a Leica TCS-SP5 spectral laser confocal microscope (Laboratorio
Integral de Microscopía, CNIA, INTA, Hurlingham, Argentina), and 40 images were analyzed using Fiji
software (Thornwood, NY, USA).
Immunofluorescence microscopy. Indirect immunofluorescence analysis was performed as previ-
ously described (74).
Statistical analyses. Statistical analyses were performed with GraphPad Prism (La Jolla, CA, USA). At
least three independent experiments were performed; error bars represent means  standard deviations.
Statistical comparisons were evaluated by using Student’s t test (unpaired, two-tailed) or one-way
analysis of variance (ANOVA) and by Bonferroni’s test. Differences between groups were considered
significant when the P value was 0.05.
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